Decreased expression of the endothelial cell-derived factor EGFL7 in systemic sclerosis: Potential contribution to impaired angiogenesis and vasculogenesis

Arthritis Research and Therapy

Volumn 15, Issue 5, 2013, Pages

  Manetti, Mirko ^a   Guiducci, Serena ^b   Romano, Eloisa ^b   Avouac, Jérôme ^c,d   Rosa, Irene ^a   Ruiz, Barbara ^c,d   Lepri, Gemma ^b   Bellando Randone, Silvia ^b   Ibba Manneschi, Lidia ^a   Allanore, Yannick ^c,d   Matucci Cerinic, Marco ^b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b CAREGGI UNIVERSITY HOSPITAL   (Italy)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d INSTITUT COCHIN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR LIKE DOMAIN 7; PROSTANOID; UNCLASSIFIED DRUG; VASODILATOR AGENT; BIOLOGICAL MARKER; EGFL7 PROTEIN, HUMAN; ENDOTHELIAL CELL GROWTH FACTOR;

ADULT; AGED; ANGIOGENESIS; ARTICLE; BLOOD SAMPLING; CELL CULTURE; COLORIMETRY; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; DOWN REGULATION; ENDOTHELIAL PROGENITOR CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FINGER ULCER; FOREARM; HUMAN; IMMUNOFLUORESCENCE TEST; MAJOR CLINICAL STUDY; MALE; MICROVASCULAR ENDOTHELIAL CELL; PATHOGENESIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SKIN BIOPSY; SYSTEMIC SCLEROSIS; WESTERN BLOTTING; BLOOD; BLOOD VESSEL; CASE CONTROL STUDY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; NEOVASCULARIZATION (PATHOLOGY); NONPARAMETRIC TEST; PATHOPHYSIOLOGY; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

ADULT; AGED; BIOLOGICAL MARKERS; BLOOD VESSELS; BLOTTING, WESTERN; CASE-CONTROL STUDIES; DOWN-REGULATION; ENDOTHELIAL GROWTH FACTORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; REFERENCE VALUES; SCLERODERMA, SYSTEMIC; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC;

EID: 84886222623     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar4349     Document Type: Article

References (22)

1. Varga J, Abraham D. Systemic sclerosis: a prototypic multisystem fibrotic disorder. J Clin Invest 2007, 117:557-567. 10.1172/JCI31139, 1804347, 17332883.
2. Matucci-Cerinic M, Kahaleh B, Wigley FM. Review: evidence that systemic sclerosis is a vascular disease. Arthritis Rheum 2013, 65:1953-1962. 10.1002/art.37988, 23666787.
3. Manetti M, Guiducci S, Ibba-Manneschi L, Matucci-Cerinic M. Mechanisms in the loss of capillaries in systemic sclerosis: angiogenesis versus vasculogenesis. J Cell Mol Med 2010, 14:1241-1254. 10.1111/j.1582-4934.2010.01027.x, 20132409.
4. Fitch MJ, Campagnolo L, Kuhnert F, Stuhlmann H. Egfl7, a novel epidermal growth factor-domain gene expressed in endothelial cells. Dev Dyn 2004, 230:316-324. 10.1002/dvdy.20063, 1458501, 15162510.
5. Nichol D, Stuhlmann H. EGFL7: a unique angiogenic signaling factor in vascular development and disease. Blood 2012, 119:1345-1352. 10.1182/blood-2011-10-322446, 3286203, 22160377.
6. Parker LH, Schmidt M, Jin SW, Gray AM, Beis D, Pham T, Frantz G, Palmieri S, Hillan K, Stainier DY, De Sauvage FJ, Ye W. The endothelial-cell-derived secreted factor Egfl7 regulates vascular tube formation. Nature 2004, 428:754-758. 10.1038/nature02416, 15085134.
7. Schmidt M, Paes K, De Mazière A, Smyczek T, Yang S, Gray A, French D, Kasman I, Klumperman J, Rice DS, Ye W. EGFL7 regulates the collective migration of endothelial cells by restricting their spatial distribution. Development 2007, 134:2913-2923. 10.1242/dev.002576, 17626061.
8. Campagnolo L, Leahy A, Chitnis S, Koschnick S, Fitch MJ, Fallon JT, Loskutoff D, Taubman MB, Stuhlmann H. EGFL7 is a chemoattractant for endothelial cells and is up-regulated in angiogenesis and arterial injury. Am J Pathol 2005, 167:275-284. 10.1016/S0002-9440(10)62972-0, 1451775, 15972971.
9. Badiwala MV, Tumiati LC, Joseph JM, Sheshgiri R, Ross HJ, Delgado DH, Rao V. Epidermal growth factor-like domain 7 suppresses intercellular adhesion molecule 1 expression in response to hypoxia/reoxygenation injury in human coronary artery endothelial cells. Circulation 2010, 122:S156-S161. 10.1161/CIRCULATIONAHA.109.927715, 20837907.
10. Gustavsson M, Mallard C, Vannucci SJ, Wilson MA, Johnston MV, Hagberg H. Vascular response to hypoxic preconditioning in the immature brain. J Cereb Blood Flow Metab 2007, 27:928-938.
11. Badiwala MV, Guha D, Tumiati L, Joseph J, Ghashghai A, Ross HJ, Delgado DH, Rao V. Epidermal growth factor-like domain 7 is a novel inhibitor of neutrophil adhesion to coronary artery endothelial cells injured by calcineurin inhibition. Circulation 2011, 124:S197-S203. 10.1161/CIRCULATIONAHA.110.011734, 21911813.
12. LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA, Rowell N, Wollheim F. Scleroderma (systemic sclerosis): classification, subsets, and pathogenesis. J Rheumatol 1988, 15:202-205.
13. Manetti M, Guiducci S, Romano E, Bellando-Randone S, Conforti ML, Ibba-Manneschi L, Matucci-Cerinic M. Increased serum levels and tissue expression of matrix metalloproteinase-12 in patients with systemic sclerosis: correlation with severity of skin and pulmonary fibrosis and vascular damage. Ann Rheum Dis 2012, 71:1064-1072. 10.1136/annrheumdis-2011-200837, 22258486.
14. Manetti M, Guiducci S, Romano E, Rosa I, Ceccarelli C, Mello T, Milia AF, Conforti ML, Ibba-Manneschi L, Matucci-Cerinic M. Differential expression of junctional adhesion molecules in different stages of systemic sclerosis. Arthritis Rheum 2013, 65:247-257. 10.1002/art.37712, 23001478.
15. Manetti M, Guiducci S, Ruffo M, Rosa I, Faussone-Pellegrini MS, Matucci-Cerinic M, Ibba-Manneschi L. Evidence for progressive reduction and loss of telocytes in the dermal cellular network of systemic sclerosis. J Cell Mol Med 2013, 17:482-496. 10.1111/jcmm.12028, 23444845.
16. Avouac J, Wipff J, Goldman O, Ruiz B, Couraud PO, Chiocchia G, Kahan A, Boileau C, Uzan G, Allanore Y. Angiogenesis in systemic sclerosis: impaired expression of vascular endothelial growth factor receptor 1 in endothelial progenitor-derived cells under hypoxic conditions. Arthritis Rheum 2008, 58:3550-3561. 10.1002/art.23968, 18975312.
17. Avouac J, Cagnard N, Distler JH, Schoindre Y, Ruiz B, Couraud PO, Uzan G, Boileau C, Chiocchia G, Allanore Y. Insights into the pathogenesis of systemic sclerosis based on the gene expression profile of progenitor-derived endothelial cells. Arthritis Rheum 2011, 63:3552-3562. 10.1002/art.30536, 21769840.
18. Fan C, Yang LY, Wu F, Tao YM, Liu LS, Zhang JF, He YN, Tang LL, Chen GD. The expression of Egfl7 in human normal tissues and epithelial tumors. Int J Biol Markers 2013, 28:71-83.
19. Nichol D, Shawber C, Fitch MJ, Bambino K, Sharma A, Kitajewski J, Stuhlmann H. Impaired angiogenesis and altered Notch signaling in mice overexpressing endothelial Egfl7. Blood 2010, 116:6133-6143. 10.1182/blood-2010-03-274860, 3031397, 20947685.
20. Nikolic I, Stankovic ND, Bicker F, Meister J, Braun H, Awwad K, Baumgart J, Simon K, Thal SC, Patra C, Harter PN, Plate KH, Engel FB, Dimmeler S, Eble JA, Mittelbronn M, Schäfer MK, Jungblut B, Chavakis E, Fleming I, Schmidt MH. EGFL7 ligates αvβ3 integrin to enhance vessel formation. Blood 2013, 121:3041-3050. 10.1182/blood-2011-11-394882, 23386126.
21. Nikolic I, Plate KH, Schmidt MH. EGFL7 meets miRNA-126: an angiogenesis alliance. J Angiogenes Res 2010, 2:9. 10.1186/2040-2384-2-9, 2901201, 20529320.
22. Beyer C, Schett G, Gay S, Distler O, Distler JH. Hypoxia in the pathogenesis of systemic sclerosis. Arthritis Res Ther 2009, 11:220. 10.1186/ar2598, 2688169, 19473554.